This filing is administrative and does not provide actionable trading signals. Monitor future Form 4 filings for insider transactions that may indicate sentiment.
Price Chart
Executive Summary
Jeffrey M. Leiden filed a Form 3 initial statement of beneficial ownership with the SEC, reporting direct and indirect holdings of Odyssey Therapeutics common stock, stock options, convertible preferred stock, and warrants. This is a routine filing required for new reporting persons and contains no material financial or operational information.
Key Facts
- Jeffrey M. Leiden filed a Form 3 initial beneficial ownership statement for Odyssey Therapeutics, Inc.
- Leiden directly owns 265,198 shares of common stock and various stock options with exercise prices between $3.98 and $4.18.
- Indirect holdings include Series B, C, D convertible preferred stock and Series D warrants held by Racing Beach Ventures LLC.
- No changes to the company's operations, financials, or strategy are disclosed.
Financial Impact
No direct financial impact; filing merely discloses existing beneficial ownership.
Risk Factors
- No new risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-212852 |
| Document: 0001193125-26-212852-index-headers.html | 0001193125-26-212852 |
| Document: 0001193125-26-212852-index.html | 0001193125-26-212852 |
| Document: 0001193125-26-212852.txt | 0001193125-26-212852 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | 8-K | $18.99 $19.00 | ▲ +0.05% | ▼ −0.47% | $19.10 (+0.58%) |
Aug 4, 2026 12w ago | 8-K | $19.96 $20.89 | ▲ +4.66% | ▲ +4.86% | $19.10 (−4.31%) |
Jun 17, 2026 18w ago | 8-K | $19.07 $18.72 | ▼ −1.84% | ▼ −1.52% | $19.10 (+0.16%) |
May 11, 2026 24w ago | Insider Cluster | $17.45 $17.90 | ▲ +2.58% | ▲ +2.72% | $19.10 (+9.46%) |
May 8, 2026 24w ago | 424B4 | $17.45 $17.90 | ▲ +2.58% | ▲ +2.72% | $19.10 (+9.46%) |
May 8, 2026 24w ago | EFFECT | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.10 (+16.32%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.10 (+16.32%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.10 (+16.32%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.10 (+16.32%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.10 (+16.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers